Industry Disruptors

June 2018

Quality Measurement: Benefits, Costs, and Future Directions

June 2018

Drugs: Pharmaceutical Pricing Reforms, Debate, and Possibilities

October 2018

Single Payer Healthcare: New Developments in Structure, Cost, and Politics

October 2018

Case Study - Sovaldi: The Emergence of Cost-Effective yet Unaffordable Cures for Formerly Intractable Conditions

October 2018

Social Determinants of Health and the Healthcare System

October 2018

Case Study - The Maryland Model

October 2018

Measuring and Improving Healthcare Value

ZIP 2021

Healthcare Consumer Activation Through Transparency and Economic Incentives

ZIP 2021

Needs and Innovations in Behavioral Health

ZIP 2021

Biosimilars and Generic Drugs

ZIP 2021

Provider Burnout: Stressors and Solutions

ZIP 2021

The High Cost of Administrative Waste in the US

ZIP 2021

Health and Healthcare for People Incarcerated in the US

ZIP 2021

Drug Costs, Value, and Innovation

ZIP 2021

State-based Innovations in Healthcare

ZIP 2021

COVID: Moving from Emergency to the ‘New Normal’

ZIP 2022

Home-Based Care for Full-Risk Dually Eligible Beneficiaries

April 2022

The Role of Private Equity in Healthcare

April 2022

What Can a State Do? California’s New Approach to Behavioral Health

April 2022

Cybersecurity in Healthcare: Why This Matters Now

April 2022

Session 2: What We Can Learn from the ACA Marketplaces?

December 2021

Session 3 Developments in DC

December 2021

Session 4 Skipping the Middleman General Motors Contracting Directly with Henry Ford

December 2021

Session 5: Risk-Taking in Primary Care

December 2021

Session 7: Big Data, Machine Learning, and Healthcare

December 2021

Session 8: Medicare Advantage, Direct Contracting, and The Medicare “Money Machine”

December 2021